Dr. Shakir Ullah

Biography

Dr. Shakir Ullah, PhD, Post Doc is an Associate Professor of Pharmacology at the Institute of Pharmaceutical Sciences (IPS), Khyber Medical University (KMU), Peshawar. He holds a Pharm-D from the University of Malakand, an MPhil in Immunology from the National University of Science and Technology (NUST), a PhD in Pharmacology from the Institute of Basic Medical Sciences, and a Postdoctoral qualification in Neuroscience from Shantou University Medical College, China. His research interests primarily focus on neuropharmacology and neuroscience, with particular expertise in epilepsy, depression, neurodegeneration, pharmacogenomics and pharmacogenetics of CNS-acting drugs, in-silico and network pharmacology, vaccine design, CNS-acting drug discovery, and drug designing.

Dr. Ullah has extensive academic and professional experience, having served as Associate Professor at KMU since 2025, following his tenure as Assistant Professor from 2019 to 2025. His earlier academic and professional roles include Lecturer at the University of Malakand, Research Associate at KMU, Lecturer at the Margalla Institute of Health Sciences, and practicing Pharmacist at North West General Hospital and Shifa International Hospital.

He has published 41 research articles, with 38 publications in HEC W Category and 3 in HEC X Category, and has a cumulative impact factor of 120 as stated in his CV. His research portfolio includes studies in neuropharmacology, epilepsy, antidepressant mechanisms, oxidative stress, pharmacogenetics, and CNS drug discovery.

Dr. Ullah has also contributed to funded research projects, including projects supported by ORIC, Khyber Medical University, and the Higher Education Commission (HEC), covering areas such as antiepileptic drug discovery, antimicrobial resistance, diabetic wound management, and the genetic and immunological basis of autoimmune disorders.

He is actively involved in postgraduate research supervision, with extensive experience supervising and co-supervising MPhil and PhD students. He also contributes to academic administration through membership of the Board of Study, Board of Faculty, Graduate Study Committee, Ethics Committee, and Disciplinary Committee at KMU.

Research Interests

Neuropharmacology & Neuroscience.

Publications

• Investigating the Role of Vitamin D in Enhancing Duloxetine and Fluoxetine Efficacy: Mechanistic Insights Into NRF2 Activation, Oxidative Stress, and Neurochemical Modulation — Naveed Khan, Shakir Ullah, Muhammad Ilyas, Muhammad Waseem Khan , Journal (2025)
• Naveed Khan, Shakir Ullah, Muhammad Ilyas, Muhammad Waseem Khan — Sardar Ali, Saima Nawaz, Shakir Ullah, Zainab Irshad, Niaz Ali, Ahad Nawaz, Muhammad Riaz, Najm Ur Rahman , Journal (2025)
• Antidepressant effects of SY-2476: A caffeine derivative’s role in A1/A2A gene expression modulation in corticosterone-induced depressed rats — Irfan Khan, Saif Ullah, Shakir Ullah, Niaz Ali, Zilli Huma, Sedat Yaşar, Siraj Khan, Rizwan Ul Haq, Amjad Khan, Imran Khan , Journal (2025)
• Bleeding Events Associated with Rivaroxaban Therapy in Naive Patients with Nonvalvular Atrial Fibrillation: A Longitudinal Study from a Genetic Perspective with INR Follow-Up — 2 and Shujaat Ahmad Nur Ul Ain 1,2, Niaz Ali 3,* , Abid Ullah 4 , Shakir Ullah 1 , Journal (2024)
• The anticonvulsant and antioxidant effect of Rosa moschata (J) fruit extract in pentylenetetrazole induced epileptic mouse model — Imran Khan1 and Muhammad Nabi Zainab Irshad1, Samia Nawaz1, Shakir Ullah1*#, Niaz Ali1 , Journal (2024)